Flow cytometer market to expand by USD 8.17 bn

The global flow cytometer market size is estimated to grow by USD 8.17 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 15.2% during the forecast period. Increasing expenditure on r and d is driving market growth, with a trend towards increasing level of process automation. However, high cost of instruments poses a challenge.

Market driver
The flow cytometer Market is experiencing significant growth due to the increasing demand for multiparametric data analysis in various industries. Stem cell cultures and fluorescent-labeled antibodies are key applications driving market expansion. Flow cytometry is used extensively in the research and diagnosis of diseases such as cancer, HIV, and autoimmune disorders. FlowMetric Life Sciences, innovators in flow cytometry, provide instruments, software, and flow cytometry services for drug discovery and cell line development. Flow cytometry techniques like Western blotting, immunohistochemistry, and microscopy complement the analysis. Accessories like fluorochrome combinations, liquid handling robotics, and bead-based assays expand the capabilities of flow cytometry. The market caters to biotechnology, life science, and biopharmaceutical research activities, offering point-of-care diagnostics for tuberculosis, sexually transmitted diseases, and other infectious diseases. Digital signal processing enhances data analysis solutions, while cellular diagnostics and immunodeficiency disorders are other major applications. Flow cytometry instruments include microfluidic flow cytometry and PCR, and antibody-based testing is a significant trend.

Flow cytometry, a laboratory technique used for analyzing and sorting cells, has seen significant advancements in automation over the past few decades. Manual sample preparation and loading have been replaced with instruments that automate these processes. These devices feature digital interfaces and store processed information, reducing the need for human intervention. Integration with other devices and processes increases flexibility, enables continuous sample flow, and decreases processing time and supervision. Modern laboratory equipment can be integrated into a digital ecosystem, ensuring a seamless transition between processes.

Research analysis
Flow cytometry is a powerful analytical technique used in various fields of life science, biotechnology, and biopharmaceutical research activities. This technique enables the analysis of multiparametric data from individual cells using fluorescent-labeled antibodies or compounds. Stem cell cultures are increasingly utilizing flow cytometry for characterization and sorting. Control parameters such as forward and side scatter are used to identify and exclude debris and aggregates. Data analysis solutions help researchers make sense of the complex data generated. Flow cytometry services offer expertise and equipment for those without access to their own instruments. Flow cytometry is used in the diagnosis and research of various diseases, including autoimmune disorders, infectious diseases like HIV/AIDS, and cancer, as well as immunodeficiency disorders. Techniques such as Western blotting, immunohistochemistry, microscopy, and PCR are often used in conjunction with flow cytometry. Microfluidic flow cytometry and antibody-based testing are emerging applications. Flow cytometer instruments continue to advance, offering increased sensitivity, speed, and multiplexing capabilities.

Market research overview
Flow cytometry is a powerful analytical technology used to measure and analyze the physical and chemical characteristics of cells, including their size, shape, and the presence of specific markers. This technique employs the use of flow cytometers, instruments that pass single cells in suspension through a laser beam, exciting fluorescent-labeled antibodies or compounds attached to the cells. Multiparametric data is generated, allowing for the simultaneous measurement of multiple parameters. Stem cell cultures and immune cells are common applications, with flow cytometry playing a crucial role in cancer, HIV, leukemia, lymphoma, autoimmune disorders, infectious diseases, and drug discovery services. Flow cytometry analysis is essential for cell line development, immunodeficiency disorders, and biotechnology research activities. Innovations in flow cytometry include microfluidic flow cytometry, digital signal processing, point-of-care diagnostics, and cell-based flow cytometry. Accessories, software, and bead-based assays are also integral components of the flow cytometry ecosystem. FlowMetric Life Sciences and other contract service providers offer flow cytometry services to researchers and clinical testing labs. Fluorochrome combinations, liquid handling robotics, and PCR are additional tools used in conjunction with flow cytometry for various applications, including drug development activities and antibody-based testing for diseases like tuberculosis and sexually transmitted diseases. Technavio